• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPINEART SA SCARLET ALT SECURED LUMBAR ANTERIOR CAGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPINEART SA SCARLET ALT SECURED LUMBAR ANTERIOR CAGE Back to Search Results
Model Number SCA-LS 15 12-S
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Abdominal Pain (1685)
Date of Event 10/08/2021
Type of Reportable Event Serious Injury
Event or Problem Description
On 03.Jun.2024, we received a complaint from the field, from france, (see (b)(4) folder) reporting that the patient underwent a spine surgery on l4/l5 (not spineart device) and l5/s1 (spineart device) on (b)(6) 2021.Beginning of (b)(6) 2021, the patient had chills and abdominal pain, prevertebral fluid collection in front of l4/l5 prosthesis (prodisc-l) was discovered on (b)(6) 2021.The intensity degree of the adverse event was classified as moderate.A re-intervention was performed on (b)(6) 2021 to remove the prevertebral abscess.The outcome of the serious adverse event was reported as resolved on (b)(6) 2021.We report this case as the device involved is us marketed.
 
Additional Manufacturer Narrative
Investigation ongoing.
 
Additional Manufacturer Narrative
As per the case narrative, the patient complained about chills and abdominal pain beginning of (b)(6) 2021 and a prevertebral fluid collection in front of l4/l5 prosthesis (prodisc-l) was discovered on (b)(6) 2021.The intensity degree of the adverse event (ae) was classified as "moderate".A re-intervention was performed on (b)(6) 2021 to remove the prevertebral abscess.The outcome of the sae was reported as "resolved".The end date was (b)(6) 2021.The causal relationship of this event to the procedure was classified as "causal", and to device or instrument classified as "not related" by the reporting investigator.After we received the complaint, the manufacturing folder has been reviewed.The analysis on the manufacturing documents and control quality documents detected that raw materials and production processes were conforming to the specifications.(b)(4).Scientific literature reports (national library of medicine) that seroma is a common complication of abdominal surgeries, see postoperative seroma management - statpearls - ncbi bookshelf (nih.Gov) "seroma is the abnormal accumulation of serous fluid in a dead space containing plasma and lymphatic fluid.[1][2][3] it is a common complication of breast cancer surgery, plastic surgery, and abdominal wall hernia repair, with rates ranging between 15 to 85% following mastectomy and a global prevalence of 10.9% following abdominoplasty.[4][5][6] surgical procedures with extensive soft tissue dissection are more likely to transect blood and lymphatic vessels and lead to a transudative fluid collection.Cases that have undergone significant resection of tissue result in a large potential dead space, making it more difficult for flaps to adhere and creating shearing forces between tissue surfaces.This is thought to contribute to an inflammatory process with exudative fluid from tissues adding to seroma formation".Plus, seroma is part of the general adverse events listed in the clinical evaluation report (cer) (b)(4).Based on the above information, we confirm that the issue reported is not linked to the device implanted but that it is related to the procedure.Since the launch of the device, (b)(4).We close the case as is with no further action.
 
Event or Problem Description
On 03.Jun.2024, we received a complaint from the field, from (b)(6) , (see (b)(4) folder) reporting that the patient underwent a spine surgery on l4/l5 (not spineart device) and l5/s1 (spineart device) on (b)(6) 2021.Beginning of (b)(6) 2021, the patient had chills and abdominal pain, prevertebral fluid collection in front of l4/l5 prosthesis (prodisc-l) was discovered on (b)(6) 2021.The intensity degree of the adverse event was classified as moderate.A re-intervention was performed on (b)(6) 2021 to remove the prevertebral abscess.The outcome of the serious adverse event was reported as resolved on (b)(6) 2021.We report this case as the device involved is us marketed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SCARLET ALT SECURED LUMBAR ANTERIOR CAGE
Common Device Name
SCARLET ALT SECURED LUMBAR ANTERIOR CAGE
Manufacturer (Section D)
SPINEART SA
chemin du pré fleuri 3
plan-les-ouates, geneva 1228
SZ  1228
Manufacturer Contact
laure-allison verboux
chemin du pré fleuri 3
plan-les-ouates, geneva 1228
SZ   1228
MDR Report Key19594088
Report Number3007728266-2024-00008
Device Sequence Number11802220
Product Code OVD
UDI-Device Identifier07640178988057
UDI-Public(01)07640178988057
Combination Product (Y/N)N
Initial Reporter CountrySZ
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study
Initial Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date (Section B) 06/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model NumberSCA-LS 15 12-S
Device Catalogue NumberSCA-LS 15 12-S
Device Lot Number5-0628
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/03/2024
Supplement Date Received by Manufacturer06/03/2024
Initial Report FDA Received Date06/24/2024
Supplement Report FDA Received Date06/27/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age34 YR
Patient SexFemale
-
-